MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41392-026-02627-2

Медицинская библиотека · Signal transduction and targeted therapy · 2026

Synergistic immunotherapeutic effects of irreversible electroporation and CAR-NK cell therapy against hepatocellular carcinoma.

Park Joo Dong, Shin Ha Eun, Jang Hye Jung, Ko Seunghyo, An Yeon Su, Lee Jun Seob, Moon Sehoon, Seo Hyungseok, Kim Yewon, Kim Yohan, Han Jun-Hyeok, Park Chun Gwon, Kim Dong-Hyun, Park Wooram

СтатьяПеревод пока не подготовлен

Аннотация

Chimeric antigen receptor natural killer (CAR-NK) cell therapy has emerged as a promising immunotherapeutic modality with potent cytotoxicity and a favorable safety profile. However, its therapeutic efficacy is often limited by poor infiltration into tumors and the profoundly immunosuppressive tumor microenvironment (TME). In hepatocellular carcinoma (HCC), one of the leading causes of cancer-related mortality, this suppressive TME severely compromises the function of CAR-NK cells. To overcome this limitation, we developed a combinatorial strategy integrating irreversible electroporation (IRE), a clinically approved nonthermal ablation modality capable of reshaping the TME, with glypican-3 (GPC3)-targeted CAR-NK cells generated via 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP)-functionalized lipid nanoparticle (LNP)-mediated gene delivery. IRE promoted immunogenic cell death and reprogrammed the TME through the release of damage-associated molecular patterns and chemokines, notably CX3CL1, thereby enhancing NK cell infiltration. Moreover, IRE-treated HCC cells exhibited heightened susceptibility to NK-mediated cytotoxicity through elevated intracellular reactive oxygen species, establishing a mechanism of immune sensitization. When combined with LNP-engineered GPC3-specific CAR-NK cells, this approach elicited synergistic antitumor activity, as demonstrated by superior tumor lysis in vitro and robust tumor regression in various HCC models without systemic toxicity. By coupling TME remodeling of IRE with the precision and safety of LNP-engineered CAR-NK cells, we propose a durable, clinically actionable treatment paradigm to overcome resistance in solid tumors, such as HCC.

Для цитирования: Park Joo Dong, Shin Ha Eun, Jang Hye Jung, Ko Seunghyo, An Yeon Su, Lee Jun Seob, Moon Sehoon, Seo Hyungseok, Kim Yewon, Kim Yohan, Han Jun-Hyeok, Park Chun Gwon, Kim Dong-Hyun, Park Wooram. Synergistic immunotherapeutic effects of irreversible electroporation and CAR-NK cell therapy against hepatocellular carcinoma.. Signal transduction and targeted therapy. 2026. DOI: 10.1038/s41392-026-02627-2.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.